{"product_id":"scripps-6th-annual-clinical-advances-in-the-diagnosis-and-management-of-pulmonary-hypertension-2022","title":"Scripps 6th Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension 2022","description":"\u003ch2\u003eScripps 6th Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension 2022\u003c\/h2\u003e\n\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003cstrong\u003e+ Include: 8 videos + 1 pdf, size: 1 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: pulmonologist\u003c\/strong\u003e\n\u003cbr\u003e\u003ch4\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003ch4 data-canvas-width=\"205.2818749803922\"\u003e\u003cstrong\u003eConference Overview:\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003e\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003ePulmonary hypertension (PH) is a common and widely misunderstood syndrome that results from a surprisingly large number of disease processes. It can occur at any age and the risk of developing PH increases with age and other medical conditions. Great strides have been made in the past 15 years in diagnosing and treating pulmonary arterial hypertension (PAH), so the natural history of PAH is rapidly changing. On the other hand, the more common clinical variant pulmonary venous hypertension (PVH), has been largely unaffected by medical therapy. In addition, there is often a divide between those who treat PAH and clinicians whose patients have PVH and are frustrated by the lack of effective therapy. This conference will be unique in that it will cover all forms of pulmonary hypertension. Expert faculty will discuss the epidemiology of PH, how PH is diagnosed, and the poor outcomes associated with PH when left untreated. Clinicians will leave with a better understanding of the difference between PAH and PVH and why the difference matters. Therapies for PAH and PVH will also be discussed with reference to current clinical guidelines. Participants will return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003e\u003c\/div\u003e\n\u003cstrong\u003eEducational Objectives:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAfter attending this live activity, participants should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli data-canvas-width=\"205.2818749803922\"\u003eDescribe the epidemiology and pathophysiology of pulmonary hypertension.\u003c\/li\u003e\n\u003cli data-canvas-width=\"205.2818749803922\"\u003e Determine who is at risk for pulmonary hypertension and effectively diagnose patients.\u003c\/li\u003e\n\u003cli data-canvas-width=\"205.2818749803922\"\u003eRecognize the difference between PAH and PVH and how this translates into therapy.\u003c\/li\u003e\n\u003cli data-canvas-width=\"205.2818749803922\"\u003eOutline the current approach to pulmonary hypertension treatment in the presence of related or underlying diseases.\u003c\/li\u003e\n\u003cli data-canvas-width=\"205.2818749803922\"\u003e Evaluate current pharmacologic and medical management strategies for patients with pulmonary hypertension.\u003c\/li\u003e\n\u003cli data-canvas-width=\"205.2818749803922\"\u003eIncorporate novel therapies into patient care for improved outcomes.\u003c\/li\u003e\n\u003cli data-canvas-width=\"205.2818749803922\"\u003eIdentify when to refer patients for specialty treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003ebrochure_ph22.pdf\u003cbr\u003eChronic Thromboembolic Pulmonary Hypertension- Kelly Fan, MD.mp4\u003cbr\u003eInterventional Treatment of Pulmonary Hypertension and Tricuspid Disease- Curtiss Stinis, MD.mp4\u003cbr\u003eMedical Management of PAH- Optimizing Therapy- J. Thomas Heywood, MD.mp4\u003cbr\u003eNew Therapies for Pulmonary Venous Hypertension- Rajeev Mohan, MD.mp4\u003cbr\u003ePulmonary Arterial Hypertension- Diagnosis and Work-up- Ajay Srivastava, MD.mp4\u003cbr\u003ePulmonary Hypertension and Adult Congenital Heart Disease- Laith Alshawabkeh, MD.mp4\u003cbr\u003ePulmonary Venous Hypertension- J. Thomas Heywood, MD.mp4\u003cbr\u003eWhen the Right Ventricle Fails- Diagnosis and Therapy- Ajay Srivastava, MD.mp4","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954289872994,"sku":"MED-AMB00368","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-6th-Annual-Clinical-Advances-in-the-Diagnosis-and-Management-of-Pulmonary-Hypertension-2022.jpg?v=1779370161","url":"https:\/\/meducourse.com\/products\/scripps-6th-annual-clinical-advances-in-the-diagnosis-and-management-of-pulmonary-hypertension-2022","provider":"Meducourse","version":"1.0","type":"link"}